Antibody-drug conjugates with HER2-targeting antibodies from synthetic antibody libraries are highly potent against HER2-positive human gastric tumor in xenograft models. [electronic resource]
Producer: 20190715Description: 153-165 p. digitalISSN:- 1942-0870
- Aminobenzoates -- pharmacology
- Animals
- Antibodies, Monoclonal, Humanized -- pharmacology
- Antineoplastic Agents -- pharmacology
- Humans
- Immunoconjugates -- pharmacology
- Mice
- Molecular Targeted Therapy -- methods
- Oligopeptides -- pharmacology
- Receptor, ErbB-2 -- antagonists & inhibitors
- Stomach Neoplasms -- pathology
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.